Uptick in interest for FDA-approved oral medication to help lower 'bad' cholesterol

Lipfendra, the first FDA-approved oral PCSK-9 medication, offers a new daily pill option that lowers LDL cholesterol by 50-60%, complementing statins for patients who haven't reached target cholesterol levels. The oral form is attracting significant interest from doctors and patients.

This Wire brief sits within Fusion42's coverage of Health.